When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.
Be alerted of any news about your stocks and see what other stocks are trending.
MBIO - Mustang Bio gene therapy for bubble boy disease nabs RMAT tag in U.S.; shares up 12% premarket
Mustang Bio Inc.
Thinly traded micro cap Mustang Bio (NASDAQ:MBIO) is up 12% premarket on light volume in response to its announcement that the FDA has designated MB-107, its lentiviral gene therapy, a Regenerative Medicine Advanced Therapy (RMAT) for the treatment of a rare inherited disorder called X-linked severe combined immunodeficiency, also known as bubble boy disease, named for child who was placed in a protective enclosure due to the profound infection risk since he had no functioning immune system.
More news on: Mustang Bio, Inc., Healthcare stocks news, Stocks on the move,